BridgeBio is substantially improved its development of an innovative solution for amyloid heart disease, leveraging Attruby. Early clinical information reveals potential outcomes for patients suffering with this serious illness. This effort highlights the company’s dedication to managing critical medical requirements in a heart field. Attruby: B